Skip to content

The role of abdominal muscle training in combination with pelvic floor muscle training to treat female urinary incontinence. A pilot study

Does training of the transversus abdominis muscle provide an additional clinical benefit to the training of pelvic floor muscles in female urinary incontinence?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14126416
Enrollment
64
Registered
2023-05-31
Start date
2009-05-30
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of female stress and female stress predominant urinary incontinence Urological and Genital Diseases

Interventions

Pelvic floor muscle and transversus abdominis muscle training under physiotherapist control Interventions: All subjects underwent routine assessment with a detailed urological, medical and gynecologi

Sponsors

Aristotle University of Thessaloniki
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Women =18 years old and over 2. At least a 3-month history of stress urinary incontinence (SUI) or mixed urinary incontinence (MUI) with a predominant stress component 3. At least 7 incontinence episodes per week, as recorded in a 3-day bladder diary 4. The enrolled women should have a positive cough stress test (CST) and a grade 3 or 4 PFM contraction based on the PERFECT Assessment Scheme

Exclusion criteria

Exclusion criteria: 1. Daytime frequency (>8 micturitions per day) or nocturia (>1 voidings per night) 2. Neurogenic incontinence or systemic diseases such as diabetes mellitus, or chronic kidney disease 3. Previously received medications for incontinence or had undergone any type of continence surgery 4. Pregnancy

Design outcomes

Primary

MeasureTime frame
Incontinence episodes measured using a 3-day bladder dairy at baseline and week 12 (end of the study)

Secondary

MeasureTime frame
The following secondary outcome measures are assessed at baseline and week 12 (end of the study): 1. Overall health status measured using the King's Health Questionnaire (KHQ) 2. Patient's impression of improvement measured using the Patient Global Impression of Improvement (PGI-I) scoring 3. Quality of life measured using the Quality of life (QoL) scoring 4. Sexual function measured using the Female Sexual Function Index (FSFI) scoring 5. The change in the strength of pelvic floor muscles measured using the PERFECT assessment scheme

Countries

Greece

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 21, 2026